The page is the record's research on the issuer — no analyst, no rating, no view. # IMMUPHARMA PLC (AIM: IMM) — research page As of 2026-11-06 · uk-cm-kg · record version 1 ## Identity and listing The issuer is IMMUPHARMA PLC, listed on AIM under ticker IMM, with ISIN GB0033711010 and LEI 213800VZKGHXC7VUS895. Its security type is Corporate, its segment is AMSM, its sector is Pharmaceuticals and Biotechnology [201030], and its jurisdiction is England and Wales (Companies House jurisdiction field). The record shows the issuer as listed, not halted. ## The disclosure read The record holds 25 filings in the twelve months to 2026-11-06, across 22 filing days. The median gap between filing days is 8 days, against a median of 7.0 days for AIM and 6.0 days for Pharmaceuticals and Biotechnology [201030]. The latest filing is dated 2026-09-10 and is an early warning, 57 days before the record date. Median filings are 33.5 for AIM and 42 for the sector, and median latency is 4 days for AIM and 4.0 days for the sector. ## Auditor The auditor of record is Crowe U.K. LLP. Its location is not on the record. Auditor changes are not on the record. ## Events and halts Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag is clear: listed, not halted. ## Orderability For elective professional client, the signal is ACM-200 and the outcome is determinable. For eligible counterparty, the signal is ACM-200 and the outcome is determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations page. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The market's vintage is not sealed. The live record began on 2026-09-11. Years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed. ## Sources 10 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange) - https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/IMM (identity.isin) - https://find-and-update.company-information.service.gov.uk/company/03929567 (identity.jurisdiction) - https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei) - https://www.londonstockexchange.com/stock/IMM/immupharma-plc/company-page (identity.sector) - https://mcp.uk-cm-kg.ai/events/AIM/IMM (the disclosure lines) - https://marketsecurities.fca.org.uk/officiallist (the halt flag) - https://www.immupharma.co.uk/wp-content/uploads/2025/10/IMM-Final-Report-Accounts-end-Dec-2024-1.pdf (the auditor) - https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.uk-cm-kg.ai/record/AIM/IMM (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/uk/AIM/IMM · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp